Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  AstraZeneca plc    AZN   GB0009895292

ASTRAZENECA PLC (AZN)

81
Delayed Quote. Delayed London Stock Exchange - 11/24 11:35:03 am
4711 GBp   -0.63%
5h ago ASTRAZENECA : Publication of Final Terms
5h ago FTSE rally pauses near two-month high as Petrofac slump weighs
11h ago ASTRAZENECA : Duaklir genuair approved in the eu for copd
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

UK Health Watchdog Backs Lung Cancer Drug From Roche

05/09/2012 | 07:16pm US/Eastern

The U.K.'s health-care watchdog said in final draft guidance Thursday that it is recommending the use of Roche Holding AG's (ROG.VX) Tarceva as a treatment option for advanced-stage lung-cancer patients.

The National Institute for Health and Clinical Excellence, known as NICE, decides what medicines should be used in the U.K.'s publicly-funded National Health Service. It said the drug--whose chemical name is erlotinib--is a cost-effective use of NHS resources.

NICE, which has already recommended AstraZeneca PLC's (>> AstraZeneca plc) Iressa, or gefitinib, for non-small-cell lung cancer, said that while there isn't any trial data directly comparing the two drugs, clinical specialists say the drugs are "very similar and equally as effective."

"We are pleased to be able to recommend another treatment option for this stage of the disease," said NICE Director Carole Longson.

The watchdog said its decision to back the drug came after it requested more information about it from the Swiss drug maker.

Roche wasn't immediately available for comment.

NICE said the draft guidance is now with consultees, who have the opportunity to appeal against it.

-By Marta Falconi, Dow Jones Newswires; +41 43 443 8043; marta.falconi@dowjones.com

Stocks mentioned in the article : AstraZeneca plc, AstraZeneca plc
React to this article
Latest news on ASTRAZENECA PLC
5h ago ASTRAZENECA : Publication of Final Terms
5h ago FTSE rally pauses near two-month high as Petrofac slump weighs
8h ago ASTRAZENECA : announces plans to expand its Frederick, Maryland biologics manufa..
11h ago ASTRAZENECA : Duaklir genuair approved in the eu for copd
11h ago ASTRAZENECA : Duaklir® Genuair® approved in the European Union for chronic obstr..
13h agoDJASTRAZENECA : EU Approves AstraZeneca Pulmonary Disease Inhaled Treatment
13h ago ASTRAZENECA : Gets EU Approval For Duaklir Genuair COPD Treatment
3d ago ASTRAZENECA : Announces USD20M Expansion At Frederick Biologics Center
3d ago ASTRAZENECA : Announces Plans to Expand its Frederick, Maryland Biologics Manufa..
3d ago ASTRAZENECA : Beactica Appoints Magnus Bjorsne To Its Board Of Directors
Advertisement
Chart
Duration : Period :
AstraZeneca plc Technical Analysis Chart | AZN | GB0009895292 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF